NCT03321825View on ClinicalTrials.gov

Evaluation of the Merz Cheek Fullness Assessment Scale in the Treatment of Midface Volume Deficit

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 29, 2017

Primary Completion Date

January 8, 2018

Study Completion Date

January 8, 2018

Conditions
Moderate to Severe Midface Volume Deficit
Interventions
DEVICE

Belotero® Volume Lidocaine

Mode of application: subdermal injection

Trial Locations (3)

L6J 7W5

Institute of Cosmetic and Laser Surgery; Merz Inverstigational Site #0010409, Oakville

M4W 2N2

Research Toronto; Merz Investigational Site #0010408, Toronto

M5R 3N8

Cosmetic Dermatology Toronto Yorkville; Merz Investigational Site #'0010412, Toronto

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT03321825 - Evaluation of the Merz Cheek Fullness Assessment Scale in the Treatment of Midface Volume Deficit | Biotech Hunter | Biotech Hunter